1. Home
  2. CGEM vs WNC Comparison

CGEM vs WNC Comparison

Compare CGEM & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • WNC
  • Stock Information
  • Founded
  • CGEM 2016
  • WNC 1985
  • Country
  • CGEM United States
  • WNC United States
  • Employees
  • CGEM N/A
  • WNC N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • CGEM Health Care
  • WNC Industrials
  • Exchange
  • CGEM Nasdaq
  • WNC Nasdaq
  • Market Cap
  • CGEM 482.7M
  • WNC 457.3M
  • IPO Year
  • CGEM 2021
  • WNC 1991
  • Fundamental
  • Price
  • CGEM $6.29
  • WNC $11.37
  • Analyst Decision
  • CGEM Strong Buy
  • WNC Hold
  • Analyst Count
  • CGEM 8
  • WNC 1
  • Target Price
  • CGEM $27.25
  • WNC $9.50
  • AVG Volume (30 Days)
  • CGEM 550.4K
  • WNC 481.9K
  • Earning Date
  • CGEM 11-06-2025
  • WNC 10-23-2025
  • Dividend Yield
  • CGEM N/A
  • WNC 2.84%
  • EPS Growth
  • CGEM N/A
  • WNC N/A
  • EPS
  • CGEM N/A
  • WNC N/A
  • Revenue
  • CGEM N/A
  • WNC $1,720,560,000.00
  • Revenue This Year
  • CGEM N/A
  • WNC N/A
  • Revenue Next Year
  • CGEM N/A
  • WNC $18.05
  • P/E Ratio
  • CGEM N/A
  • WNC N/A
  • Revenue Growth
  • CGEM N/A
  • WNC N/A
  • 52 Week Low
  • CGEM $6.24
  • WNC $6.78
  • 52 Week High
  • CGEM $18.62
  • WNC $20.63
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 33.86
  • WNC 52.37
  • Support Level
  • CGEM $6.44
  • WNC N/A
  • Resistance Level
  • CGEM $6.76
  • WNC $11.63
  • Average True Range (ATR)
  • CGEM 0.41
  • WNC 0.33
  • MACD
  • CGEM -0.10
  • WNC -0.43
  • Stochastic Oscillator
  • CGEM 2.83
  • WNC 95.95

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: